Source MDx Announces Partnership with Brigham and Women’s Hospital to Study RNA-Based Biomarkers for Multiple Sclerosis

Source MDx today announced a partnership with Brigham and Women's Hospital in Boston to examine RNA-based biomarkers in multiple sclerosis (MS) patients and healthy control participants unaffected by the disease. The goal of the study is to identify diagnostic markers and to determine markers of active disease (relapses) or stable disease, along with response markers [...]

FEI’s New TrueCrystal Package Provides Rapid, Accurate Strain Profiling for Semiconductor Manufacturing

Automated strain analysis package combines ease of use with reduced time to data Hillsboro, Ore./November 3, 2008¯FEI Company (Nasdaq: FEIC), a leading provider of atomic-scale imaging and analysis systems, today released its new TrueCrystal Strain Analysis package that can be installed on a Titan™ or Tecnai™ scanning/transmission electron microscope (S/TEM) system. The new, automated strain [...]

Celera Appoints Scott K. Milsten as General Counsel

Celera (NASDAQ:CRA) today announced the appointment of Scott K. Milsten as Vice President, General Counsel and Corporate Secretary, effective immediately. Mr. Milsten will report to Kathy Ordonez, Celera's Chief Executive Officer. Mr. Milsten was most recently Deputy General Counsel for Gen-Probe Incorporated (NASDAQ:GPRO). In this capacity, he managed corporate governance and securities compliance, and structured [...]

Tripos International Completes Acquisition of Pharsight Corporation

Tripos International, the leading provider of drug discovery informatics products and services, today announced that it has completed the acquisition of Pharsight Corporation, a leader in software, strategic and regulatory services designed to optimize clinical drug development. The transaction, valued at approximately $57 million, moves Pharsight into the Tripos portfolio. In making the announcement, Tripos' [...]

Source MDx Announces Partnership with Brigham and Women’s Hospital to Study RNA-Based Biomarkers for Multiple Sclerosis

Source MDx today announced a partnership with Brigham and Women's Hospital in Boston to examine RNA-based biomarkers in multiple sclerosis (MS) patients and healthy control participants unaffected by the disease. The goal of the study is to identify diagnostic markers and to determine markers of active disease (relapses) or stable disease, along with response markers [...]

See Colonies in a Whole New Light!

The new ColonyDoc-It Imaging Station from UVP is configured with multiple light sources for illuminating colonies. An integrated digital color camera captures high resolution co lony images. The easy to use process enables accurate and automated colony counting. Alex Waluszko, Vice President for Marketing and Sales at UVP states, “The automated, software-controlled design of the [...]

Sartorius Stedim Biotech Acquires Wave Biotech AG

Sartorius Stedim Biotech GmbH (SSB) (Paris:DIM), a group subsidiary of the biotechnology supplier Sartorius Stedim Biotech, signed an agreement to acquire the Swiss-based technology company Wave Biotech AG. Both companies have already been closely working together since 2006. In addition to their joint research projects, Sartorius Stedim Biotech has been exclusively marketing Wave's entire product [...]

MDS Analytical Technologies Announces Availability of New High-Throughput Method to Detect Melamine in Food

SUNNYVALE, CA and WARMINSTER, PA, Oct. 30 - MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life-sciences research, today announced that the Abraxis Melamine Detection Kit has been validated for use on MDS Analytical Technologies' SpectraMax® absorbance microplate readers with SoftMax® Pro 5 GxP analytical software, an industry-standard analysis software for [...]

InteRNA Technologies and VU University Medical Center to Develop microRNA-Based Diagnostics and Therapeutics for Cancer

BILTHOVEN and AMSTERDAM, The Netherlands, October 30 -- InteRNA Technologies B.V. and VU university medical center in Amsterdam, VUmc, announce today the signing of a framework research agreement to develop microRNA (miRNA)-based diagnostics and therapeutics for cancer using InteRNA's proprietary library of miRNAs. Under the research collaboration, InteRNA will apply its unique lentiviral-based miRNA overexpression [...]

GE Security Receives General Services Administration Approval Of Updated Contract, Launches Authorized GSA Service Provider Program

GE Security, Inc., a business of GE Enterprise Solutions (NYSE:GE), today announced the company has modified its contract with the General Services Administration (GSA) to update the schedule of available GE Security products. With the updated contract, GE Security's authorized GSA service providers will have the ability to sell GE Security products and provide service [...]

Access IBO on Knowledge Center